Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

July 22, 2002

Selective PARP1/PARP2 inhibitors described by Iconix R&D team

July 22, 2002

New Tie-2 and/or VEGFR-2 inhibitors and their use in cancer

July 22, 2002

TNFerade enters phase IIb trial in advanced pancreatic cancer

July 19, 2002

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

July 19, 2002

Novel antineoplastic antibiotics produced by Streptomyces

July 19, 2002

Angiostatin enters phase II program

July 19, 2002

Phase II begins for irofulven + irinotecan in advanced gastrointestinal solid tumors

July 18, 2002

Procyon and Chiron extend PSP94 technology option agreement

July 18, 2002

Telik exercises option to develop compounds from Arizona Cancer Center collaboration

July 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...